FGFBP2 Antikörper (AA 121-220) (Biotin)

Produktnummer ABIN1390357

Produktdetails anti-FGFBP2 Antikörper (Biotin)

Target: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Bindungsspezifität: AA 121-220

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser FGFBP2 Antikörper ist konjugiert mit Biotin

Applikation: ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))

Kreuzreaktivität: Human

Aufreinigung: Purified by Protein A.

Immunogen: KLH conjugated synthetic peptide derived from human FGFBP2/KSP37

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: IHC-P 1:200-400
IHC-F 1:100-500

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Lagerung: -20 °C

Informationen zur Lagerung: Store at -20°C for 12 months.

Haltbarkeit: 12 months

Details zu FGFBP2

Target: FGFBP2 (Fibroblast Growth Factor Binding Protein 2 (FGFBP2))

Andere Bezeichnung: FGFBP2/KSP37 (FGFBP2 Produkte)

Synonyme: fb08g06 antikoerper, wu:fb08g06 antikoerper, HBP17RP antikoerper, KSP37 antikoerper, fibroblast growth factor binding protein 2 antikoerper, fibroblast growth factor binding protein 2a antikoerper, fibroblast growth factor binding protein 2 L homeolog antikoerper, FGFBP2 antikoerper, fgfbp2a antikoerper, fgfbp2.L antikoerper

Hintergrund:

Synonyms: FGF-binding protein 2, FGF-BP2, FGFBP-2, FGFBP2, FGFP2_HUMAN, Fibroblast growth factor-binding protein 2, HBp17-related protein, HBp17-RP, Ksp37, 37 kDa killer-specic secretory protein.

Background: KSP37 is a 223 amino acid protein that is secreted into the extracellular space and belongs to the fibroblast growth factor-binding protein family. Expressed in serum, as well as in cytotoxic T lymphocytes and peripheral leukocytes, KSP37 is thought to be involved in lymphocyte-mediated immunity, possibly playing a role in the development of asthma. The gene encoding KSP37 maps to human chromosome 4, which encodes nearly 6 % of the human genome and has the largest gene deserts (regions of the genome with no protein encoding genes) of all of the human chromosomes. Defects in some of the genes located on chromosome 4 are associated with Huntington's disease, Ellis-van Creveld syndrome, methylmalonic acidemia and polycystic kidney disease.